First, evaluation of cell viability with the MTT assay demonstrated that ADAM32 could increase cell viability in the HBL, HBCs, and breast cancer cell lines evaluated by forced expression and knockdown experiments. The gene discussed is ADAM32; the disease is breast carcinoma.